Verrica Pharmaceuticals Inc. Shares Issued, Price Per Share
Verrica Pharmaceuticals Inc. (VRCA) had Shares Issued, Price Per Share of $8.90 per share as of 2024-11-30, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesIssuedPricePerShare · last filed 2026-03-11
- 2024-11-30: Shares Issued, Price Per Share $8.90.
- 2024-11-22: Shares Issued, Price Per Share $0.89.
- 2023-02-28: Shares Issued, Price Per Share $6.75.
- 2023-02-23: Shares Issued, Price Per Share $6.75.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2024-11-30 | $8.90 10-K · filed 2026-03-11 |
| 2024-11-22 | $0.89 10-Q · filed 2025-05-13 |
| 2023-02-28 | $6.75 10-Q · filed 2023-11-09 |
| 2023-02-23 | $6.75 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |